In vitro and in vivo evaluation of diethyldithiocarbamate with copper ions and its liposomal formulation for the treatment of Staphylococcus aureus and Staphylococcus epidermidis biofilms

Simple item page
dc.contributor.authorKaul, L.
dc.contributor.authorAbdo, A.I.
dc.contributor.authorCoenye, T.
dc.contributor.authorSwift, S.
dc.contributor.authorZannettino, A.
dc.contributor.authorSüss, R.
dc.contributor.authorRichter, K.
dc.date.issued2023
dc.descriptionAvailable online 17 May 2023
dc.description.abstractSurgical site infections (SSIs) are mainly caused by Staphylococcus aureus (S. aureus) and Staphylococcus epidermidis (S. epidermidis) biofilms. Biofilms are aggregates of bacteria embedded in a self-produced matrix that offers protection against antibiotics and promotes the spread of antibiotic-resistance in bacteria. Consequently, antibiotic treatment frequently fails, resulting in the need for alternative therapies. The present study describes the in vitro efficacy of the Cu(DDC)2 complex (2:1 M ratio of diethyldithiocarbamate (DDC−) and Cu2+) with additional Cu2+ against S. aureus and S. epidermidis biofilms in models mimicking SSIs and in vitro antibacterial activity of a liposomal Cu(DDC)2 + Cu2+ formulation. The in vitro activity on S. aureus and S. epidermidis biofilms grown on two hernia mesh materials and in a wound model was determined by colony forming unit (CFU) counting. Cu2+-liposomes and Cu(DDC)2-liposomes were prepared, and their antibacterial activity was assessed in vitro using the alamarBlue assay and CFU counting and in vivo using a Galleria mellonella infection model. The combination of 35 μM DDC− and 128 μM Cu2+ inhibited S. aureus and S. epidermidis biofilms on meshes and in a wound infection model. Cu(DDC)2-liposomes + free Cu2+ displayed similar antibiofilm activity to free Cu(DDC)2 + Cu2+, and significantly increased the survival of S. epidermidis-infected larvae. Whilst Cu(DDC)2 + Cu2+ showed substantial antibiofilm activity in vitro against clinically relevant biofilms, its application in mammalian in vivo models is limited by solubility. The liposomal Cu(DDC)2 + Cu2+ formulation showed antibiofilm activity in vitro and antibacterial activity and low toxicity in G. mellonella, making it a suitable water-soluble formulation for future application on infected wounds in animal trials.
dc.description.statementofresponsibilityLaurine Kaul, Adrian I. Abdo, Tom Coenye, Simon Swift, Andrew Zannettino, Regine Süss, Katharina Richter
dc.identifier.citationBiofilms, 2023; 5:100130-1-100130-10
dc.identifier.doi10.1016/j.bioflm.2023.100130
dc.identifier.issn1479-0505
dc.identifier.issn2590-2075
dc.identifier.orcidKaul, L. [0000-0002-8820-036X]
dc.identifier.orcidAbdo, A.I. [0000-0002-6329-8954]
dc.identifier.orcidZannettino, A. [0000-0002-6646-6167]
dc.identifier.orcidRichter, K. [0000-0003-2979-8215]
dc.identifier.urihttps://hdl.handle.net/2440/138504
dc.language.isoen
dc.publisherElsevier BV
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/GNT1163634
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/2004036
dc.rights© 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
dc.source.urihttps://doi.org/10.1016/j.bioflm.2023.100130
dc.subjectSurgical site infections; Diethyldithiocarbamate; Copper ions; Liposomes; Staphylococcus aureus; Staphylococcus epidermidis
dc.titleIn vitro and in vivo evaluation of diethyldithiocarbamate with copper ions and its liposomal formulation for the treatment of Staphylococcus aureus and Staphylococcus epidermidis biofilms
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_138504.pdf
Size:
3.16 MB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

IPAS publications
Pharmacology publications
Surgery publications